Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burleson Research Technologies (BRT) is a specialized contract research organization (CRO) focused on preclinical immunotoxicology and immune safety assessment. Founded in 1996, the company provides a comprehensive suite of laboratory services to the biotechnology, pharmaceutical, and chemical industries to evaluate the efficacy and safety of novel therapeutics. BRT's expertise spans in vitro immune function evaluations, in vivo infectious disease models, and specialized assays for cytokines and the complement system. The company is recognized for its high-quality data and client-centric approach in supporting the development of pharmaceuticals, biologics, and vaccines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Technologies.